EXO BIOLOGICS

What this means for you

Not registered yet, but its 18 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98320218

Mark type

Stylized text

Filed

18 Dec 2023

Attorney of record

Neil B Friedman

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer, lung, eye, skin, gastrointestinal, inflammatory, auto-immune or infectious disorders and diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, diagnostic preparations for medical use; capsules sold empty for medicines and medical diagnostic reagents tests; chemico-pharmaceutical preparations for the prevention or treatment of cancer, lung, eye, skin, gastrointestinal, inflammatory, auto-immune or infectious disorders and diseases; biopharmaceutical products for the prevention or treatment of cancer, lung, eye, skin, gastrointestinal, inflammatory, auto-immune, or infectious disorders and diseases; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, chemical preparations for diagnosing lung, eye, skin, gastrointestinal, inflammatory, auto-immune, or infectious disorders and diseases, neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namely, probes and kits for medical and clinical diagnosis including nucleic acid libraries, nucleic acids on DNA chips; DNA libraries and RNA libraries for medical diagnostic purposes and companion diagnostic purposes; nucleic acid sequences intended for use in chips for medical purposes and medical diagnostic purposes, namely, for decoding genes affected by diseases or revealing the transcriptomic signature of patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; reagents for medical use contained in diagnostic test kits for taking blood samples required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions; none of the aforesaid goods being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software
• Class 042 — Scientific and technological services: Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical analysis services, namely, analysis of RNA genes, tissues and blood samples; scientific research in the nature of biotechnological project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analysis services, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology; Consulting services in the field of pharmaceutical research, namely, selection of individuals for clinical trials; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software
• Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; medical assistance; hospital services; preparation of prescriptions by pharmacists for geriatric or neurological diagnoses and treatment; health care; telemedicine services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software

Owner

• EXO Biologics SA, Liège, BE

Prosecution history

• 10 Oct 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 10 Oct 2025 — LETTER OF SUSPENSION E-MAILED
• 10 Oct 2025 — SUSPENSION LETTER WRITTEN
• 30 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 30 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 30 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 19 Jul 2024 — NON-FINAL ACTION E-MAILED
• 19 Jul 2024 — NON-FINAL ACTION WRITTEN
• 17 Jul 2024 — ASSIGNED TO EXAMINER
• 02 Jul 2024 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
• 02 Jul 2024 — TEAS VOLUNTARY AMENDMENT RECEIVED
• 30 Jan 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 23 Dec 2023 — NEW APPLICATION ENTERED